Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II, Randomized, Open-Label Study to Evaluate the Comparative Safety and Immunogenicity of 1.0 microg Intramuscular (i.m.) and 2.0 microg Subcutaneous (s.c.) Dosing With VAX102 (M2e-Flagellin) in Healthy Adults.

Next Previous
Trial Profile

A Phase II, Randomized, Open-Label Study to Evaluate the Comparative Safety and Immunogenicity of 1.0 microg Intramuscular (i.m.) and 2.0 microg Subcutaneous (s.c.) Dosing With VAX102 (M2e-Flagellin) in Healthy Adults.

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 26 Aug 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs VAX 102 (Primary)
  • Indications Influenza A virus infections
  • Focus Pharmacodynamics; Therapeutic Use

Most Recent Events

  • 06 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 20 Jun 2009 Official Title added, patient number added as 60, additional lead trial investigator David N Taylor, additional trial location as USA as reported by ClinicalTrials.gov.
  • 18 Jun 2009 Planned end date added as 1 Aug 2009 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top